Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting

Abstract Background Within Finland’s breast cancer screening program, all women aged 50–69 are invited to biennial screening. Current European guidelines recommend screening in ages 45–49 and 70–74 conditional upon, inter alia, demonstrated context-specific cost-effectiveness. This study aims to det...

Full description

Saved in:
Bibliographic Details
Main Authors: Filip Siegfrids, Sirpa Heinävaara, Tytti Sarkeala, Laura Niinikoski, Juha Laine
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Health Economics Review
Subjects:
Online Access:https://doi.org/10.1186/s13561-025-00628-5
Tags: Add Tag
No Tags, Be the first to tag this record!